Source: Virtual Congress 2021 – Lung disease burden and management



Rating:

Share or cite this content

Citations should be made in the following way:
T. Nery (São Paulo, Brazil), N. Bispo (São Paulo, Brazil), R. Stelmach (São Paulo, Brazil). COPD - Impact on Mortality in Locals with and without Specific Medication. 2153

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Identity Consequence Fatigue Scale (ICFS) in COPD: Correlation with Severity, Risk of Hospitalization and Length of stay Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Guideline Adherence and Identifying Cost Effective Medication Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Impact of Physical Frailty on Pulmonary Rehabilitation and Hospitalisation in COPD Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018 Assessing an Educational Intervention to Improve Recognition of Frailty in Hospitalized Patients with COPD Source: International Congress 2019 – Medical education Year: 2019 Assessment of asthma morbidity by US patients, specialists, Asthma Control Test™, and Asthma Impairment and Risk Questionnaire™ Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics Year: 2020 Comorbidities in COPD - Impact on mortality Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 The Correlation between Asthma Control and Total Rescue Asthma Medication Purchases. Source: International Congress 2018 – Asthma analysis Year: 2018 Does the Outpatient Pulmonary Rehabilitation Program Affect Mortality in Patients with COPD? Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Cardiovascular comorbidity in COPD: Tip of iceberg Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients with COVID-19- and Non-COVID-19-induced Acute Respiratory Distress Syndrome. Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure Year: 2021 Patient and Public Involvement (PPI) in TANDEM: A Tailored intervention for ANxiety and DEpression Management in COPD Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 The Impact of Current Smoking on Severe Asthma in the Wessex Severe Asthma Cohort Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Population Screening for COPD: A comparison of COPD Patient Screener and CAPTURE Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Assessing the Asthma Impairment and Risk Questionnaire’s ability to predict exacerbations Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Mortality after COPD-exacerbations: Learning from epidemiology Source: International Congress 2014 – Clinical presentations Year: 2014 Risk for adverse outcomes in asthma: Assess to impress! Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 LATE-BREAKING ABSTRACT: The development of a Patient Reported Experience Measure in COPD (PREM-COPD Stage 2) Source: International Congress 2014 – Latest insights in pulmonary rehabilitation Year: 2014 LATE-BREAKING ABSTRACT: Clinical and Epidemiological Characteristics of Hospitalized COPD Exacerbations. Source: International Congress 2014 – Predictors Year: 2014 COPD telemonitoring: Analysis of hospital admissions Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Increasing Pulmonary Rehabilitation Referrals in COPD Patients: A Quality Improvement Initiative Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation Year: 2019